NARCIS provides access to 515,512 scientific publications (205,118 of which are open access publications), 13,905 data sets, and information on researchers (expertise), research projects and research institutes in the Netherlands.
Show page in English/Toon pagina in Nederlands
 
Project: Circulating endothelial cells as markers for antiangiogenic therapy
Abstract
bullet Abstract The application of anti-angiogenic drug(combination)s in the clinic is hampered by the lacking of suitable methods for target validation and effectivity. We pursue the possibility to monitor (sub)populations of circulating endothelial cells/progenitors (CEC or CEP) in the peripheral blood (PB) of cancer patients. A study protocol has been set-up to establish the reliability and reproducibility of a 4-colour flow cytometry procedure for measuring the frequencies of subpopulations of circulating cells with endothelial markers, including CD34, AC133, P1H12 (CD146), CD31, CD105, in particular in combination with a newly available VEGFR2 antibody. CD45 low , CD31 bright , P1H12, VEGFR2 weakly positive subpopulations could be reproducibly measured in cancer patients (CECs). CD45 dim , CD34 bright , VEGFR2 positive cells (CEPs) appeared to be present in very low frequencies in PB. The first studies, that measure CECs and CEPs in cancer patients treated with VEGF(R)-targeted agents, bevacizumab and sunitinib are ongoing and results are currently being analysed. In vitro cultures of endothelial progenitor cells from human umbilical cord blood have been established as models for tumor(-growth promoting) endothelial cells. The effects of concurrent VEGFR and EGFR blocking agents on the proliferative, invasive and tube-forming capacity will be studied.
Related organisations
bullet Secretariat Onderzoekschool Oncologie Amsterdam - OOA (VU)
bullet Collaboration Cancer Center Amsterdam / VUmc Institute for Cancer and Imunology - CCA/V-ICI (VU)
bullet Financier Europese Commissie
Related people
bullet Researcher Drs. L. Vroling
bullet Project leader Dr. H.J. Broxterman
Related research (upper level)
bullet Program Prevention and therapy of tumors
Classification
bullet A70000 Public health and health care
bullet D21500 Histology, cell biology
bullet D23120 Oncology
bullet D23340 Biopharmacology, toxicology
Data Supplier: Website OOA; Website V-ICI
Update this data in the Dutch Research Database (NOD).